Keywords: PTSD; Metabolomics; Glycomics; Clinical data; Animal models; Theranostic biomarkers; Patients; ACTH; adenocorticotropic hormone; APCI; atmospheric pressure chemical ionization; BDNF; brain derived neurotropic factor; CE; capillary electrophoresis; CE-MS;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: 2-AG; 2-arachidonoylglycerol; AD; atopic dermatitis; AEA; arachidonoylethanolamide; DAGL; diacylglycerol lipase; eCB; endocannabinoid; ECS; endocannabinoid system; EMT; endocannabinoid membrane transporter; FAAH; fatty acid amide hydrolase; LPS; lipopolys
Keywords: AEA; anandamide; BS; behavioral sensitization; CB1; cannabinoid receptor type 1; CB2; cannabinoid receptor type 2; CL; conditioned locomotion; Coc; cocaine; CPP; conditioned place preference; CS+; positive conditioned stimulus; CS-; neutral conditioned st
Keywords: Fattening; Adiposity; Endocannabinoid; CB1; Oleoylethanolamide; Palmitoylethanolamide;
Keywords: Palmitoylethanolamide; Micronization; Antisolvent; Supercritical fluids;
Keywords: Contrast-induced nephropathy; Palmitoylethanolamide; Inflammation; Nephrectomy
Keywords: Diacerein; NAAA; Palmitoylethanolamide; Inflammation;
Keywords: 2-AG; 2-arachidonylglycerol; 2-OG; 2-oxogluteric acid; AEA; N-arachidonoylethanolamide; CB1; cannabinoid type 1 receptor; CB1â/â/CB2â/â; CB1 and CB2 deficient; CB2; cannabinoid type 2 receptor; CK; cytokeratin; DAGLα; diacylglycerol lipase α; DA
Keywords: Palmitoylethanolamide; oleoylethanolamide; anandamide; endocannabinoid system; seminal plasma;
Keywords: N-Acylethanolamine; N-Acylphosphatidylethanolamine; N-Acyltransferase; Oleoylethanolamide; Palmitoylethanolamide; Phospholipase
Production of PEA composite microparticles with polyvinylpyrrolidone and luteolin using Supercritical Assisted Atomization
Keywords: Supercritical Assisted Atomization; Palmitoylethanolamide; Polyvinylpyrrolidone; Luteolin; Composite microparticles; Coprecipitation;
Scp-2/Scp-x ablation in Fabp1 null mice differentially impacts hepatic endocannabinoid level depending on dietary fat
Keywords: Mouse; Liver; FABP1; Gene ablation; Endocannabinoid; High fat diet; AEA; n-6 arachidonoylethanolamide (anandamide); 2-AG; 2-arachidonoyl glycerol; ARA; arachidonic acid; CB1; cannabinoid receptor-1; DAGLα; diacylglycerol lipase A; DHA; n-3 docosahexaenoi
Topically Applied Nicotinamide Inhibits Human Hair Follicle Growth Ex Vivo
Keywords: HF; hair follicle; MC; mast cell; PEA; palmitoylethanolamide;
The N-Acylethanolamine Acid Amidase Inhibitor ARN077 Suppresses Inflammation and Pruritus in a Mouse Model of Allergic Dermatitis
Keywords: NAAA; N-acylethanolamine acid amidase; OEA; oleoylethanolamide; PEA; palmitoylethanolamide;
Altered neural responsivity to food cues in relation to food preferences, but not appetite-related hormone concentrations after RYGB-surgery
Keywords: 2-AG; 2-arachidonoylglycerol; BMI; body mass index; BOLD; blood oxygenation level-dependent; DARTEL; diffeomorphic anatomical registration through exponentiated lie algebra; DHEA; docosahexaenoylethanolamide; DLE; dihomo-γ-linoleonylethanolamide; eCB; en
Palmitoylethanolamide as adjunctive therapy for autism: Efficacy and safety results from a randomized controlled trial
Keywords: Autism; Endocannabinoid system; Hyperactivity; Inflammation; Irritability; Palmitoylethanolamide; Randomized controlled trial;
Acute and Chronic Pain Processing in the Thalamocortical System of Humans and Animal Models
Keywords: ASL; arterial spin labeling; NS; nociceptive specific; PAG; periaqueductal gray; PEA; palmitoylethanolamide; PET; positron emission tomography; S1; somatosensory cortex; SPECT; single photon emission tomography; SpV; spinal trigeminal nucleus; SRT; spinor
Adelmidrol + sodium hyaluronate in IC/BPS or conditions associated to chronic urothelial inflammation. A translational study
Keywords: CYP; cyclophosphamide; IC/BPS; interstitial cystitis/painful bladder syndrome; MCs; mast cells; iNOS; nitric oxide synthase; ZO-1; zonula occludens type 1; PEA; palmitoylethanolamide; MPO; Myeloperoxidase; (NF-κB) p65; nuclear factor-κB; (IL)-1β; inter
Research PaperThe interaction between alpha 7 nicotinic acetylcholine receptor and nuclear peroxisome proliferator-activated receptor-α represents a new antinociceptive signaling pathway in mice
Keywords: nAChRs; α7 nicotinic acetylcholine receptors; PPAR-α; nuclear peroxisome proliferator-activated receptors type-α; PAMs; positive allosteric modulators; ago-PAMs; ago-allosteric ligands; PEA; palmitoylethanolamide; OEA; oleoylethanolamide; CB1 and CB2;
Pharmacological inhibition of FAAH modulates TLR-induced neuroinflammation, but not sickness behaviour: An effect partially mediated by central TRPV1
Keywords: 2-AG; 2-arachidonoyl glycerol; CB; cannabinoid; FAAH; fatty acid amide hydrolyase; i.c.v.; intracerebroventricular; IL; interleukin; NFκB; nuclear factor kappa B; LPS; lipopolysaccharide; OEA; oleoylethanolamide; PEA; palmitoylethanolamide; PPAR; peroxis
Mammalian enzymes responsible for the biosynthesis of N-acylethanolamines
Keywords: N-acyltransferase; Anandamide; Glycerophosphodiesterase; Oleoylethanolamide; Palmitoylethanolamide; Phospholipase;
N-acylethanolamine-hydrolyzing acid amidase and fatty acid amide hydrolase inhibition differentially affect N-acylethanolamine levels and macrophage activation
Keywords: ABHD4; α/β-hydrolase domain 4; AEA; N-arachidonoylethanolamine; DHEA; N-docosahexaenoylethanolamine; DTEA; N-docosatetraenoylethanolamine; FAAH; fatty acid amide hydrolase; GDE1; glycerophosphodiester phosphodiesterase 1; NAAA; N-acylethanolamine-hydrol
Effects of a co-micronized composite containing palmitoylethanolamide and polydatin in an experimental model of benign prostatic hyperplasia
Keywords: Inflammation; Palmitoylethanolamide; Polydatin; Benign prostatic hyperplasia;
Oleic acid-derived oleoylethanolamide: A nutritional science perspective
Keywords: ABHD4; α/β-hydrolase domain-containing protein 4; AEA; arachidonoylethanolamide; A:G; android-to-gynoid; CHO; carbohydrate; DHEA; docosahexaenoylethanolamide; DXA; dual-energy X-ray absorptiometry; E; energy; EEA; elaidoylethanolamide; FAAH; fatty acid
Progress in the development of β-lactams as N-Acylethanolamine Acid Amidase (NAAA) inhibitors: Synthesis and SAR study of new, potent N-O-substituted derivatives
Keywords: N-Acylethanolamine acid amidase; Cysteine hydrolase; N-O-Substituted β-lactams; Inhibitors; Structure-activity relationships (SAR); NAAA; N-acylethanolamine acid amidase; FAEs; fatty acid ethanolamides; OEA; oleoylethanolamide; PEA; palmitoylethanolami
Adelmidrol increases the endogenous concentrations of palmitoylethanolamide in canine keratinocytes and down-regulates an inflammatory reaction in an in vitro model of contact allergic dermatitis
Keywords: Adelmidrol; Entourage effect; Inflammation; Keratinocytes; Palmitoylethanolamide;
MALDI MSI analysis of lipid changes in living skin equivalents in response to emollient creams containing palmitoylethanolamide
Keywords: MALDI MSI; Matrix-Assisted Laser Desorption Ionisation Mass Spectrometry Imaging; PCA; Principal Component Analysis; PEA; Palmitoylethanolamide; LLP; Light liquid paraffin; MALDI MSI; MALDI; MS imaging; Lipids; Skin; Emollients; Living skin equivalents;
Salivary concentration of N-acylethanolamines upon food mastication and after meal consumption: Influence of food dietary fiber
Keywords: βGB; β-glucan biscuits; WWBB; whole-wheat bran biscuits; CB; control biscuits; NAEs; N-acylethanolamines; OEA; oleoylethanolamide; LEA; linoleoylethanolamide; PEA; palmitoylethanolamide; ECs; endocannabinoids; 2-AG; 2-acylglycerol; AEA; arachidonylethan
Palmitoylethanolamide protects mice against 6-OHDA-induced neurotoxicity and endoplasmic reticulum stress: In vivo and in vitro evidence
Keywords: PEA; palmitoylethanolamide; PPAR; peroxisome proliferator activated receptor; PD; Parkinson's disease; DA; dopamine; ER; endoplasmic reticulum; UPR; unfolded protein response; eIF-2α; elongation initiation factor-2α; 6-OHDA; 6-hydroxydopamine; MPTP; 1
Ultramicronized palmitoylethanolamide (PEA-um®) in the treatment of idiopathic pulmonary fibrosis
Keywords: Palmitoylethanolamide; Idiopathic pulmonary fibrosis; Lung; Disease; Mice;
Endocannabinoid concentrations in hair are associated with PTSD symptom severity
Keywords: Posttraumatic stress disorder; Endocannabinoids; Hair; Palmitoylethanolamide; Oleoylethanolamine; Stearoylethanolamine; Mass spectrometry;
Oxylipins, endocannabinoids, and related compounds in human milk: Levels and effects of storage conditions
Keywords: DHET; dihydroxy-eicosatrienoic acid; HETE; hydroxy-eicosatetraenoic acid; LTB4; leukotriene B4; EpOME; epoxy-octadecenoic acid; EET; epoxy-eicosatrienoic acid; TXB2; thromboxane B2; PGD2; prostaglandin D2; HODE; hydroxy-octadecadienoic acid; DiHOME; dihyd
Supercritical fluids based techniques to process pharmaceutical products difficult to micronize: Palmitoylethanolamide
Keywords: Supercritical fluids; Palmitoylethanolamide; Micronization; Microparticles; Anti-inflammatory; Neuroprotective
Interaction between the protective effects of cannabidiol and palmitoylethanolamide in experimental model of multiple sclerosis in C57BL/6 mice
Keywords: Î9-THC; delta-9-tetrahydrocannabinol; AEA; anandamide; ALS; amyotrophic lateral sclerosis; AMT; anandamide membrane transporter; ANOVA; analysis of variance; CBD; cannabidiol; CBs; Cannabinoids; CFA; complete Freund's adjuvant; CNS; central nervous sys
Feeding-induced oleoylethanolamide mobilization is disrupted in the gut of diet-induced obese rodents
Keywords: CCK; Cholecystokinin; DIO; Diet-induced Obesity; FAE; Fatty Acid Ethanolamide; GLP-1; Glucagon-like peptide-1; LC-MS; Liquid Chromatography-Mass Spectrometry; LEA; Linoleoylethanolamide; OEA; Oleoylethanolamide; PEA; Palmitoylethanolamide; PYY; Peptid
Palmitoylethanolamide treatment reduces retinal inflammation in streptozotocin-induced diabetic rats
Keywords: Diabetic retinopathy; Palmitoylethanolamide; Streptozotocin; Inflammation
A quantitiative LC-MS/MS method for the measurement of arachidonic acid, prostanoids, endocannabinoids, N-acylethanolamines and steroids in human plasma
Keywords: LC-MS/MS; Arachidonic acid; Endocannabinoids; Lipids; Steroids; N-acylethanolamines; Palmitoylethanolamide; Prostanoids; Noladin etherAA, arachidonic acid; ACN, acetonitrile; AEA, anandamide; ALDO, aldosterone; 2-AG, 2-arachidonoyl glycerol; A-GABA, N-ara
Palmitoylethanolamide inhibits rMCP-5 expression by regulating MITF activation in rat chronic granulomatous inflammation
Keywords: Chronic inflammation; Palmitoylethanolamide; Rat mast cell protease; Microphtalmia-associated Transcription Factor
Advances in the discovery of N-acylethanolamine acid amidase inhibitors
Keywords: N-Acylethanolamine acid amidase; Fatty acid ethanolamides; Palmitoylethanolamide; Pain; Inflammation; NAAA inhibitorsPalmitoylethanolamide (PubChem CID: 4671); Oleoylethanolamide (PubChem CID: 5283454); N-Pentadecylbenzamide (PubChem CID: 44398681); N-Pen
Changes in endocannabinoid and N-acylethanolamine levels in rat brain structures following cocaine self-administration and extinction training
Keywords: AEA; anandamide; 2-AG; 2-arachidonoylglycerol; eCBs; endocannabinoids; LC-MS/MS; liquid chromatography tandem mass spectrometry; NAEs; N-acylethanolamines; OEA; oleoylethanolamide; PEA; palmitoylethanolamide; “Yoked” procedure; Cocaine self-administra
Targeting inflammation: New therapeutic approaches in chronic kidney disease (CKD)
Keywords: ACEI; Angiotensin-converting enzyme inhibitor; ARB; angiotensin receptor blocker; CKD; chronic kidney disease; DN; diabetic nephropathy; ESRD; end stage renal disease; PEA; palmitoylethanolamide; PPARα; proliferator activated receptor alpha; TNF-α; tumo
N-Palmitoylethanolamide protects the kidney from hypertensive injury in spontaneously hypertensive rats via inhibition of oxidative stress
Keywords: PEA; palmitoylethanolamide; PPAR; peroxisome proliferator-activated receptor; PPRE; peroxisome proliferator response elements; Ang II; Angiotensin II; RAAS; renin-angiotensin aldosterone system; SHR; spontaneously hypertensive rats; WKY; Wistar Kyoto; SBP
Antinociceptive effects of the N-acylethanolamine acid amidase inhibitor ARN077 in rodent pain models
Keywords: λ-Carrageenan; Chronic constriction injury; Oleoylethanolamide; Palmitoylethanolamide; Peroxisome proliferator-activated receptor-α; UVB-induced erythema;
Palmitoylethanolamide and stearoylethanolamide levels in the interstitium of the trapezius muscle of women with chronic widespread pain and chronic neck-shoulder pain correlate with pain intensity and sensitivity
Keywords: N-Acylethanolamines; Cannabinoid; Palmitoylethanolamide; Pain; Microdialysis; Myalgia; Widespread pain;
Effects of palmitoylethanolamide on the cutaneous allergic inflammatory response in Ascaris hypersensitive Beagle dogs
Keywords: Hypersensitivity; Canine; IgE; Ascaris suum; Palmitoylethanolamide
N-(4-Methoxy-2-nitrophenyl)hexadecanamide, a palmitoylethanolamide analogue, reduces formalin-induced nociception
Keywords: N-(4-Methoxy-2-nitrophenyl)hexadecanamide; Palmitoylethanolamide; Anandamide; Cannabinoid receptors; Antinociception; Fatty acid amide hydrolase;
Involvement of the peroxisome proliferator-activated receptor (PPAR) alpha in vascular response of endocannabinoids in the bovine ophthalmic artery
Keywords: Anandamide; Palmitoylethanolamide; Ophthalmic artery; Peroxisome proliferators-activated receptor alpha; Nitric oxide;
The endocannabinoid system in inflammatory bowel diseases: from pathophysiology to therapeutic opportunity
Keywords: N-arachidonoylethanolamine; endocannabinoids; inflammatory bowel disease; anandamide; 2-arachidonoylglycerol; palmitoylethanolamide; monoacylglycerol lipase; fatty acid amide hydrolase
Alteration of the endocannabinoid system in mouse brain during prion disease
Keywords: prion; endocannabinoid; cannabinoid receptor; neurodegenerative disease; brain; mouse; AEA; arachidonoylethanolamide or anandamide; CBD; cannabidiol; CBR; cannabinoid receptor; CJD; Creutzfeldt-Jakob disease; GAPDH; glyceraldehyde-3-phosphate dehydrogenas
Il sistema endocannabinoide: attuali conoscenze e potenziali applicazioni in odontostomatologia
Keywords: Endocannabinoidi; N-aciletanolamine; Palmitoiletanolamide; Chirurgia orale; Odontostomatologia; Endocannabinoids; N-acylethanolamines; Palmitoylethanolamide; Oral surgery; Odontostomatology;